Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

MiMedx Group, Inc (MDXG) had Revenue of $118.09M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$118.09M
Net Income	$15.19M
Cost of Goods Sold	$19.05M
Gross Profit	$99.04M
Operating Expenses	$97.02M
Operating Income	$21.08M
Non-Operating Income/Expense	$0.72M
Pre-Tax Income	$21.79M
Normalized Pre-Tax Income	$21.79M
Income after Taxes	$15.19M
Income from Continuous Operations	$15.19M
Consolidated Net Income/Loss	$15.19M
Normalized Income after Taxes	$15.19M
EBIT	$21.08M
EBITDA	$24.30M
Weighted-Average Shares Outstanding (Basic)	147.79M
Weighted-Average Shares Outstanding (Diluted)	149.72M
Earnings per Share (EPS) (Basic)	$0.10
Earnings per Share (EPS) (Diluted)	$0.10
Balance Sheet Financials
Current Assets	$277.47M
Property, Plant, and Equipment	$4.71M
Long-Term Assets	$65.18M
Total Assets	$342.65M
Current Liabilities	$64.27M
Long-Term Debt	$16.47M
Long-Term Liabilities	$21.84M
Total Liabilities	$86.11M
Common Equity	$256.55M
Tangible Shareholders Equity	$222.95M
Shareholders Equity	$256.55M
Common Shares Outstanding	148.09M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$74.00M
Cash Flow from Investing Activities	$-6.89M
Cash Flow from Financial Activities	$-5.41M
Beginning Cash	$104.42M
End Cash	$166.12M
Increase/Decrease in Cash	$61.70M
Stock-Based Compensation	$16.40M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.32
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.07
Gross Margin	83.86%
Operating Margin	17.85%
EBIT Margin	17.85%
EBITDA Margin	--
Pre-Tax Profit Margin	18.45%
Profit Margin	12.86%
Free Cash Flow	$72.97M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.34
Inventory Turnover	0.75
Receiveable Turnover	1.56
Days Sales in Receivables	57.70
Return on Equity	5.92%
Return on Tangible Equity	6.81%
Return on Assets	4.43%
Return on Investments	5.56%
Book Value Per Share	$1.73
Free Cash Flow per Share	$0.49
Operating Cash Flow per Share	$0.49

Data from Zacks Investment Research, Inc.